loadpatents
name:-0.028884887695312
name:-0.020125150680542
name:-0.017863035202026
ORENGO; Jamie M. Patent Filings

ORENGO; Jamie M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for ORENGO; Jamie M..The latest application filed is for "methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist".

Company Profile
16.16.27
  • ORENGO; Jamie M. - Cortlandt Manor NY
  • Orengo; Jamie M. - Cortland Manor NY
  • ORENGO; Jamie M. - Corlandt Manor NY
  • Orengo; Jamie M - Cortlandt Manor NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Methods For Treating Peanut Allergy And Enhancing Peanut Allergen-specific Immunotherapy By Administering An Il-4r Antagonist
App 20220220211 - ORENGO; Jamie M. ;   et al.
2022-07-14
Method of treating an allergy with allergen-specific monoclonal antibodies
Grant 11,352,417 - Orengo , et al. June 7, 2
2022-06-07
Methods Of Treating Allergy Using Anti-bet V 1 Antibodies
App 20220002394 - Atanasio; Amanda ;   et al.
2022-01-06
Anti-IL-33 Antibodies and Uses Thereof
App 20210363236 - Murphy; Andrew J. ;   et al.
2021-11-25
Anti-IL-33 antibodies and uses thereof
Grant 11,104,729 - Murphy , et al. August 31, 2
2021-08-31
Diagnostic Tests And Methods For Assessing Safety, Efficacy Or Outcome Of Allergen-specific Immunotherapy (sit)
App 20210148929 - YANCOPOULOS; George D. ;   et al.
2021-05-20
Methods of Treating Inflammatory Conditions
App 20210079105 - Orengo; Jamie M. ;   et al.
2021-03-18
Human Antibodies To Bet V 1 And Methods Of Use Thereof
App 20210054056 - Orengo; Jamie M. ;   et al.
2021-02-25
Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof
Grant 10,851,158 - Orengo , et al. December 1, 2
2020-12-01
Methods of treating inflammatory conditions
Grant 10,815,305 - Orengo , et al. October 27, 2
2020-10-27
Human antibodies to Bet v 1 and methods of use thereof
Grant 10,793,624 - Orengo , et al. October 6, 2
2020-10-06
Methods For Treating Allergy And Enhancing Allergen-specific Immunotherapy By Administering An Il-4r Inhibitor
App 20200299393 - Stahl; Neil ;   et al.
2020-09-24
IL-33 antagonists and uses thereof
Grant 10,774,128 - Murphy , et al. Sept
2020-09-15
Anti-il-25 Antibodies And Uses Thereof
App 20200262912 - ORENGO; Jamie M. ;   et al.
2020-08-20
Method Of Treating An Allergy With Allergen-specific Monoclonal Antibodies
App 20200255503 - Kind Code
2020-08-13
Anti-il2 Receptor Gamma Antigen-binding Proteins
App 20200247894 - Kind Code
2020-08-06
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor
Grant 10,676,530 - Stahl , et al.
2020-06-09
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor
Grant 10,669,341 - Stahl , et al.
2020-06-02
Anti-IL-25 antibodies and uses thereof
Grant 10,640,558 - Orengo , et al.
2020-05-05
Anti-IL-33 Antibodies and Uses Thereof
App 20200071396 - Murphy; Andrew J. ;   et al.
2020-03-05
Anti-fc Epsilon-r1 Alpha (fcer1a) Antibodies, Bispecific Antigen-binding Molecules That Bind Fcer1a And Cd3, And Uses Thereof
App 20200062844 - Orengo; Jamie M. ;   et al.
2020-02-27
Nucleic acids encoding IL-33 antibodies
Grant 10,519,230 - Murphy , et al. Dec
2019-12-31
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor
Grant 10,392,439 - Stahl , et al. A
2019-08-27
Human Antibodies To Bet V 1 And Methods Of Use Thereof
App 20180346555 - Orengo; Jamie M. ;   et al.
2018-12-06
IL-33 Antagonists and Uses Thereof
App 20180265567 - Murphy; Andrew J. ;   et al.
2018-09-20
Biomarkers Related to Interleukin-33 (IL-33)-Mediated Diseases and Uses Thereof
App 20180258164 - Orengo; Jamie M. ;   et al.
2018-09-13
Anti-IL-33 Antibodies and Uses Thereof
App 20180251542 - Murphy; Andrew J. ;   et al.
2018-09-06
IL-33 antagonists and uses thereof
Grant 10,011,647 - Murphy , et al. July 3, 2
2018-07-03
Biomarkers related to interleukin-33 (IL-33)-mediated diseases and uses thereof
Grant 10,005,834 - Orengo , et al. June 26, 2
2018-06-26
Methods of treating an inflammatory condition or sensitivity to an allergen with anti-IL-33 antibodies
Grant 10,000,564 - Murphy , et al. June 19, 2
2018-06-19
Methods of Treating Inflammatory Conditions
App 20180155436 - ORENGO; Jamie M. ;   et al.
2018-06-07
Methods for Treating Allergy and Enhancing Allergen-Specific Immunotherapy by Administering an IL-4R Inhibitor
App 20180094069 - Stahl; Neil ;   et al.
2018-04-05
Methods for Treating Allergy and Enhancing Allergen-Specific Immunotherapy by Administering an IL-4R Inhibitor
App 20180094070 - Stahl; Neil ;   et al.
2018-04-05
Anti-il-25 Antibodies And Uses Thereof
App 20180057583 - ORENGO; Jamie M. ;   et al.
2018-03-01
Anti-IL-25 antibodies and uses thereof
Grant 9,840,557 - Orengo , et al. December 12, 2
2017-12-12
IL-33 Antagonists and Uses Thereof
App 20170204158 - Murphy; Andrew J. ;   et al.
2017-07-20
Biomarkers Related to Interleukin-33 (IL-33)-Mediated Diseases and Uses Thereof
App 20170096483 - Orengo; Jamie M. ;   et al.
2017-04-06
Anti-IL-33 Antibodies and Uses Thereof
App 20160362487 - Murphy; Andrew J. ;   et al.
2016-12-15
Anti-IL-33 antibodies
Grant 9,453,072 - Murphy , et al. September 27, 2
2016-09-27
Anti-IL-25 Antibodies and Uses Thereof
App 20160083466 - ORENGO; Jamie M. ;   et al.
2016-03-24
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R inhibitor
App 20140356372 - STAHL; Neil ;   et al.
2014-12-04
Anti-il-33 Antibodies And Uses Thereof
App 20140271658 - Murphy; Andrew J. ;   et al.
2014-09-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed